Literature DB >> 2946680

Insulin-like growth factors, insulin, and epidermal growth factor cause rapid cytoskeletal reorganization in KB cells. Clarification of the roles of type I insulin-like growth factor receptors and insulin receptors.

T Kadowaki, S Koyasu, E Nishida, H Sakai, F Takaku, I Yahara, M Kasuga.   

Abstract

Insulin-like growth factor (IGF) I (greater than or equal to 10(-10)M, insulin-like growth factor II (greater than or equal to 10(-9) M), insulin (greater than or equal to 10(-9) M, and epidermal growth factor (EGF, greater than or equal to 10(-11) M) caused rapid membrane ruffling in KB cells. The morphological change was observed within 1 min after the addition of these growth factors and was accompanied by microfilament reorganization, but not by microtubule reorganization. IGF-I, IGF-II, and insulin induced morphologically very similar or identical membrane ruffles with the order of potency IGF-I greater than IGF-II greater than insulin, whereas EGF-induced membrane ruffles were morphologically different. KB cells possessed EGF receptors, type I IGF receptors, and insulin receptors, but few or no type II IGF receptors. Monoclonal antibody against type I IGF receptors, which completely inhibited the binding of 125I-IGF-I to the cells but did not inhibit the binding of 125I-insulin, caused marked inhibition of IGF-I (10(-8) M)-stimulated membrane ruffling. IGF-II (10(-8) M)-stimulated membrane ruffling was partially inhibited in the presence of this antibody, but insulin (10(-7) M)-stimulated membrane ruffling was only slightly inhibited. In contrast, monoclonal antibody against insulin receptors blocked insulin (10(-7) M) stimulation, but not IGF-I (10(-8) M) stimulation, of membrane ruffling. Thus, this study provides evidence that IGF-I and insulin act mostly through their own (homologous) receptors and that IGF-II acts by cross-reacting with both type I IGF and insulin (heterologous) receptors in causing rapid alterations in cytoskeletal structure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2946680

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Mesangial cell activation by bacterial endotoxin. Induction of rapid cytoskeletal reorganization and gene expression.

Authors:  S L Bursten; F Stevenson; F Torrano; D H Lovett
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

2.  Insulin induces changes in the subcellular distribution of actin and 5'-nucleotidase.

Authors:  A Vedeler; I F Pryme; J E Hesketh
Journal:  Mol Cell Biochem       Date:  1991-11-13       Impact factor: 3.396

3.  Glioma-derived PDGF-related protein presents as 17 kd intracellularly and assembled form induces actin reorganization.

Authors:  T Nakamura; I Takeshita; M Fukui
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

4.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.

Authors:  J E Segall; S Tyerech; L Boselli; S Masseling; J Helft; A Chan; J Jones; J Condeelis
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

5.  Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response.

Authors:  J J Grzesiak; M D Pierschbacher
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Role of insulin receptor and insulin signaling on αPS2CβPS integrins' lateral diffusion.

Authors:  Dipak Mainali; Aleem Syed; Neha Arora; Emily A Smith
Journal:  Eur Biophys J       Date:  2014-10-21       Impact factor: 1.733

7.  Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

Authors:  V F Tapson; M Boni-Schnetzler; P F Pilch; D M Center; J S Berman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

8.  Functional and morphological effects of tumour necrosis factor alpha in an interleukin 6-producing pulmonary large cell carcinoma with sarcomatoid features.

Authors:  T Motoyama; H Watanabe; T Kumanishi; H Usui; H Hashimoto; T Hachisu; I Fukamachi; T Arai; K Takehara
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 9.  Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective.

Authors:  Mitchell Kamrava; David Gius; Giovanna Casagrande; Elise Kohn
Journal:  Ageing Res Rev       Date:  2009-11-05       Impact factor: 10.895

10.  Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins.

Authors:  L Liu; L Chen; J Chung; S Huang
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.